dicloxacillin has been researched along with cefuroxime in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sørensen, TS | 1 |
| Cars, O | 1 |
| Lanbeck, P; Paulsen, O | 2 |
| Cuevas, SF; Gonzalez, SN; Palacios, GC; Perez, FL; Solorzano, SF | 1 |
| Espersen, F; Frimodt-Møller, N; Skov, R | 1 |
| Berisa, AE; Georgoulis, AD; Lykissas, MG; Manoudis, GN; Mitsionis, GI; Motsis, E; Sionti, I | 1 |
| Benfield, T; Frimodt-Møller, N; Knudsen, JD; Nissen, JL; Ostergaard, C; Schønheyder, HC; Skov, R | 1 |
| Crane, JK | 1 |
| Arpi, M; Benfield, T; Knudsen, JD; Ostergaard, C; Rasmussen, JB; Schønheyder, HC | 1 |
| Andersen, C; Jensen-Fangel, S; Kahl, BC; Nørskov-Lauritsen, N; Olesen, HV | 1 |
| Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Blom, J; Frimodt-Møller, N; Hessler, JH; Sandberg, A; Skov, RL | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for dicloxacillin and cefuroxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dicloxacillin and cefuroxime
| Article | Year |
|---|---|
Cefuroxime vs a dicloxacillin/chloramphenicol combination for the treatment of parapneumonic pleural effusion and empyema in children.
Topics: Cefuroxime; Cephalosporins; Child, Preschool; Chloramphenicol; Dicloxacillin; Drug Administration Schedule; Drug Therapy, Combination; Empyema, Pleural; Female; Humans; Infant; Male; Penicillins; Pleural Effusion; Treatment Outcome | 2002 |
20 other study(ies) available for dicloxacillin and cefuroxime
| Article | Year |
|---|---|
Comparative in vitro activity of four beta-lactam antibiotics in surgical wound fluid against staphylococci.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalothin; Culture Media; Dicloxacillin; Hip Fractures; Humans; Methicillin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Surgical Wound Infection | 1985 |
Tissue distribution of beta-lactam antibiotics. Experimental studies in rabbits.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefuroxime; Dicloxacillin; Extracellular Space; Female; Histocytochemistry; Injections, Intramuscular; Injections, Intravenous; Male; Methods; Muscles; Protein Binding; Rabbits; Tissue Distribution | 1981 |
Cytotoxic effects of four antibiotics on endothelial cells.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cattle; Cefuroxime; Cell Survival; Cells, Cultured; Cephalosporins; Dicloxacillin; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Erythromycin; Humans; Infant, Newborn; Penicillin G; Penicillins; Platelet Aggregation Inhibitors; Proteins; Serotonin Antagonists | 1995 |
Short-term effects of four antibiotics on DNA synthesis in endothelial cells.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefuroxime; Cells, Cultured; Dicloxacillin; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythromycin; Humans; Nucleic Acid Synthesis Inhibitors; Penicillin G; Thymidine; Time Factors; Umbilical Veins | 2001 |
In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefuroxime; Dicloxacillin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Statistics, Nonparametric | 2002 |
Pyomyositis in children: early diagnosis and treatment.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Combined Modality Therapy; Dicloxacillin; Drainage; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Pyomyositis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2009 |
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cefuroxime; Cohort Studies; Denmark; Dicloxacillin; Female; Humans; Male; Middle Aged; Penicillins; Propensity Score; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
Topics: Anti-Bacterial Agents; Bacteremia; Cefuroxime; Dicloxacillin; Female; Humans; Male; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Dicloxacillin; Female; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Propensity Score; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2014 |
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Dicloxacillin; Disk Diffusion Antimicrobial Tests; Female; Humans; Infant; Infant, Newborn; Male; Recurrence; Respiratory Tract Infections; Retrospective Studies; Sputum; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2014 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
Topics: Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Colony Count, Microbial; Dicloxacillin; Dose-Response Relationship, Drug; Female; Humans; Mice; Microbial Sensitivity Tests; Peritoneum; Peritonitis; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |